Experts tell Congress how to cut drug prices
December 12, 2017
The nation's most influential science advisory group will tell Congress today that the U.S. pharmaceutical market is not sustainable and needs to change.
"Drugs that are not affordable are of little value and drugs that do not exist are of no value," said Norman Augustine, chair of the National Academies of Sciences, Engineering and Medicine's committee on drug pricing and former CEO of Lockheed Martin Corp.
https://www.news-medical.net/news/20171212/Experts-tell-Congress-how-to-cut-drug-prices.aspx
